Addus HomeCare Corporation (ADUS)
NASDAQ: ADUS · IEX Real-Time Price · USD
94.18
-0.36 (-0.38%)
At close: Apr 29, 2024, 4:00 PM
93.65
-0.53 (-0.56%)
After-hours: Apr 29, 2024, 5:56 PM EDT

Addus HomeCare Revenue

In the year 2023, Addus HomeCare had annual revenue of $1.06B with 11.31% growth. Revenue in the quarter ending December 31, 2023 was $276.35M with 11.86% year-over-year growth.

Revenue (ttm)
$1.06B
Revenue Growth
+11.31%
P/S Ratio
1.46
Revenue / Employee
$30,381
Employees
34,846
Market Cap
1.54B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.06B107.53M11.31%
Dec 31, 2022951.12M86.62M10.02%
Dec 31, 2021864.50M99.72M13.04%
Dec 31, 2020764.78M115.98M17.88%
Dec 31, 2019648.79M132.14M25.58%
Dec 31, 2018516.65M90.65M21.28%
Dec 31, 2017425.99M25.07M6.25%
Dec 31, 2016400.93M64.11M19.04%
Dec 31, 2015336.82M23.87M7.63%
Dec 31, 2014312.94M47.00M17.67%
Dec 31, 2013265.94M21.63M8.85%
Dec 31, 2012244.32M14.21M6.18%
Dec 31, 2011230.11M6.00K0.00%
Dec 31, 2010230.10M-29.21M-11.26%
Dec 31, 2009259.31M23.00M9.73%
Dec 31, 2008236.31M41.74M21.45%
Dec 31, 2007194.57M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Warby Parker 669.77M
Taro Pharmaceutical Industries 610.83M
U.S. Physical Therapy 604.80M
UFP Technologies 400.07M
Zai Lab 266.72M
ADMA Biologics 258.22M
Avadel Pharmaceuticals 27.96M
Inhibrx 1.80M
Revenue Rankings